CompletedNot Applicable

Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing Program

Thailand401 participantsStarted 2025-04-01

Plain-language summary

This study is a cross-sectional study. The study aims to determine the levels of immunity against hepatitis B virus and varicella-zoster virus in medical students.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Medical students * Age 18 years or older Exclusion Criteria: * Known cases of hepatitis B virus infection * Known cases of varicella-zoster virus infection

What they're measuring

The seroprevalence of hepatitis B virus

Timeframe: From enrollment to the end of treatment at 6 months

The seroprevalence of varicella-zoster virus

Timeframe: From enrollment to the end of treatment at 6 months

Trial details

NCT IDNCT06901362

SponsorThammasat University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-31

View on ClinicalTrials.gov More Healthy trials